Insiders · Profile

Goldberg Andrew D.

Director at Tarsus Pharmaceuticals. Filing since 15 Dec 2023. CIK 0001827722

Company

Date

Role

Action

Shares

Amount

Of holding

TARS Tarsus Pharmaceuticals, Inc.

15 Dec 2023

Director

Bought

1,000

$18.96K

50.0%

1 decision on file.